×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Section 249: Advanced LSVT Voice and Speech Therapy in CBS/P
therapeutic
3,295 words
KG: ent-dise-bfd8f32d
2026-03-25
section:therapeutics
kind:therapeutic
topic:cbs
topic:psp
topic:lsvt
topic:speech-therapy
topic:voice-therapy
topic:augmentative-communication
topic:advanced-rehabilitation
Contents
Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP
💊
Therapeutic Info
Name
Section 249: Advanced LSVT Voice and Speech Therapy in CBS/PSP
Summary
Advanced LSVT LOUD protocols, voice amplification devices, speech intelligibility exercises, augmentative communication, and caregiver communication strategies for CBS/PSP
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Purinergic Signaling Polarization Control
Score: 0.55
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.46
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
PARP1 Inhibition Therapy
Score: 0.58
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes
Score: 0.57
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli
Score: 0.57
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.51
Ganglioside Rebalancing Therapy
Score: 0.50
Lysosomal Calcium Channel Modulation Therapy
Score: 0.49
Orexin-Microglia Modulation Therapy
Score: 0.49
Microglial Purinergic Reprogramming
Score: 0.48
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
Complement C1q Mimetic Decoy Therapy
Score: 0.48
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Arginine Methylation Enhancement Therapy
Score: 0.46
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.45
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45
HCN1-Mediated Resonance Frequency Stabilization Therapy
Score: 0.44
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.44
R-Loop Resolution Enhancement Therapy
Score: 0.43
Extracellular Matrix Stiffness Modulation
Score: 0.43
Glial Glycocalyx Remodeling Therapy
Score: 0.41
SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.39
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
Show 25 more
Related Analyses (23)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Show 18 more
Related Experiments (14)
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.46
Cytochrome Therapeutics
clinical · proposed · Score: 0.46
N-of-1 Clinical Trial Design for CBS/PSP
clinical · proposed · Score: 0.46
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.46
Experiment Scoring Methodology
clinical · proposed · Score: 0.46
Synaptic Vesicle Trafficking Dysfunction Validation in Parki
clinical · proposed · Score: 0.46
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.46
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.46
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.46
Show 9 more
See Also (15)
ALS Therapeutic Landscape — Programs by Phase and Modal
disease · Pages share 4 hypotheses
Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 4 hypotheses
vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 4 hypotheses
VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 4 hypotheses
Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses
Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 4 hypotheses
ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 4 hypotheses
Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 4 hypotheses
Tau Seeding and Propagation Pathway
mechanism · Pages share 4 hypotheses
T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 4 hypotheses
Systemic Infection and Tau Pathology Acceleration
mechanism · Pages share 4 hypotheses
Show 10 more